[1]周卫凤.尤瑞克林治疗脑梗死的效果及对血清学炎症因子、神经功能恢复、生活质量的影响[J].医学信息,2025,38(09):129-132.[doi:10.3969/j.issn.1006-1959.2025.09.026]
　ZHOU Weifeng.Effect of Urinary Kallidinogenase in the Treatment of Cerebral Infarction and its Influence on Serological Inflammatory Factors, Neurological Function Recovery and Quality of Life[J].Journal of Medical Information,2025,38(09):129-132.[doi:10.3969/j.issn.1006-1959.2025.09.026]
点击复制

尤瑞克林治疗脑梗死的效果及对血清学炎症因子、神经功能恢复、生活质量的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年09期
页码:
129-132
栏目:
论著
出版日期:
2025-05-01

文章信息/Info

Title:
Effect of Urinary Kallidinogenase in the Treatment of Cerebral Infarction and its Influence on Serological Inflammatory Factors, Neurological Function Recovery and Quality of Life
文章编号:
1006-1959（2025）09-0129-04
作者:
周卫凤
上饶市广丰区人民医院药剂科，江西 上饶 334600
Author(s):
ZHOU Weifeng
Department of Pharmacy, Shangrao Guangfeng District People’s Hospital, Shangrao 334600, Jiangxi, China
关键词:
尤瑞克林; 脑梗死; 神经功能
Keywords:
Urinary kallidinogenase;  Cerebral infarction;  Neurological function
分类号:
R743.33
DOI:
10.3969/j.issn.1006-1959.2025.09.026
文献标志码:
A
摘要:
目的 评价尤瑞克林治疗脑梗死的临床效果及对患者血清学炎症因子、神经功能恢复、生活质量的影响。方法 选择2020年1月-2023年12月上饶市广丰区人民医院收治的60例脑梗死患者作为研究对象，按照随机数字表法将其分为对照组和研究组，每组30例。对照组采用常规治疗，研究组在其基础上采用尤瑞克林治疗。比较两组临床疗效、血清学炎症因子[血清C反应蛋白（CRP）、白细胞介素-6（IL-6）]水平、神经功能（NIHSS评分、CSS评分）、生活质量（躯体功能、生理功能、社会功能、情感功能）。结果 与对照组治疗总有效率的73.33%比较，研究组治疗总有效率更高，为96.67%（P＜0.05）。两组治疗后血清炎症因子水平（CRP、IL-6）低于治疗前，且与对照组比较，研究组治疗后血清炎症因子水平（CRP、IL-6）更低（P＜0.05）；两组治疗后NIHSS评分、CSS评分低于治疗前，躯体功能、生理功能、社会功能及情感功能评分均高于治疗前，且与对照组比较，研究组治疗后NIHSS评分、CSS评分更低，躯体功能、生理功能、社会功能及情感功能评分更高（P＜0.05）。结论 尤瑞克林可提升脑梗死患者的临床疗效，改善患者炎性反应，提高患者生活质量和神经功能，值得临床应用。
Abstract:
Objective To evaluate the clinical effect of urinary kallidinogenase in the treatment of cerebral infarction and its effect on serum inflammatory factors, neurological function recovery and quality of life. Methods A total of 60 patients with cerebral infarction admitted to Shangrao Guangfeng District People’s Hospital from January 2020 to December 2023 were selected as the research objects, and they were divided into control group and study group according to the random number table method, with 30 patients in each group. The control group was treated with routine treatment, and the study group was treated with urinary kallidinogenase on the basis of routine treatment. The clinical efficacy, serum inflammatory factors [serum C-reactive protein (CRP), interleukin-6 (IL-6)] levels, neurological function (NIHSS score, CSS score), quality of life (physical function, physiological function, social function, emotional function) were compared between the two groups. Results Compared with 73.33% of the total effective rate of the control group, the total effective rate of the study group was higher, which was 96.67% (P<0.05). The levels of serum inflammatory factors (CRP, IL-6) in the two groups after treatment were lower than those before treatment, and compared with the control group, the levels of serum inflammatory factors (CRP, IL-6) in the study group after treatment were lower (P<0.05). The NIHSS score and CSS score of the two groups after treatment were lower than those before treatment, the scores of physical function, physiological function, social function and emotional function were higher than those before treatment, and compared with the control group, the NIHSS score and CSS score of the study group after treatment were lower, and the scores of physical function, physiological function, social function and emotional function were higher (P<0.05). Conclusion Urinary kallidinogenase can improve the clinical efficacy of patients with cerebral infarction, improve the inflammatory response, improve the quality of life and neurological function of patients, which is worthy of clinical application.

参考文献/References:

[1]陈丽君,赵文杰,陈浩,等.胞磷胆碱钠胶囊联合尤瑞克林治疗急性脑梗死的效果及对血清Hcy、CRP水平的影响[J].中国现代医学杂志,2023,33(16):55-59.[2]李波,张婷,周遥,等.尤瑞克林联合阿替普酶静脉溶栓对急性脑梗死患者神经功能及血液流变学的影响[J].中国现代医学杂志,2022,32(24):74-78.[3]潘耀新,杨昕翰.尤瑞克林治疗急性脑梗死的疗效及促进患者神经功能恢复和改善疾病相关指标的研究[J].中国临床医生杂志,2022,50(11):1325-1329.[4]杨莉,杨玉美,忽胜和,等.法舒地尔联合尤瑞克林治疗急性脑梗死的效果及对血清SAA、Lp-PLA2与凝血功能的影响[J].河北医药,2021,43(18):2767-2770.[5]刘仲秋,初建峰.尤瑞克林联合阿替普酶溶栓治疗急性脑梗死的疗效及对神经功能与炎症因子的影响[J].临床荟萃,2021,36(6):509-512.[6]中华中医药学会脑病分会,广东省中医药学会脑病专业委员会,广东省中西医结合学会卒中专业委员会.中西医结合脑卒中循证实践指南(2019)[J].中国循证医学杂志,2020,20(8):901-912.[7]甄诚,曹宾,刘明,等.丁苯酞和尤瑞克林联合治疗老年脑梗死进展期患者疗效及对患者凝血功能和神经功能缺损的影响[J].实用医院临床杂志,2020,17(2):116-119.[8]贾云朋,韩雪娟,陈乐乐,等.尿激酶静脉溶栓联合尤瑞克林治疗急性脑梗死效果观察及对血清MMP-9、VEGF水平的影响[J].临床误诊误治,2020,33(12):33-38.[9]黄德波,冯国宽,毛献泉,等.尤瑞克林联合血栓通对急性缺血性脑梗死患者的临床效果及对患者神经功能缺损评分变化与日常生活能力的影响[J].国际精神病学杂志,2019,46(6):1063-1066.[10]华立波,孙兴成,袁伟峰,等.尤瑞克林通过ERK1/2通路对急性脑梗死大鼠HO-1、p-GSK-3β蛋白水平表达的影响[J].脑与神经疾病杂志,2019,27(11):673-676.[11]李小裴,周盛年.马来酸桂哌齐特联合尤瑞克林治疗急性脑梗死的疗效及对血液流变学和血清IL-10、TNF-α、hs-CRP的影响[J].中西医结合心脑血管病杂志,2018,16(6):785-788.[12]李丹,韩冰.醒脑静注射液、尤瑞克林联合治疗对脑梗死病人神经功能缺损及脑血流动力学的影响[J].中西医结合心脑血管病杂志,2018,16(7):846-848.[13]杜明洋,邱峰,曹辉,等.尤瑞克林联合丁苯酞胶囊对急性脑梗死患者血清学指标及认知功能的影响[J].中国药师,2018,21(11):1971-1974.[14]刘满卓,王慧,赵素霞,等.尤瑞克林联合血管内介入对急性脑梗死患者神经功能、炎性因子和血液流变学的影响[J].现代生物医学进展,2020,20(13):2556-2559,2511.[15]辛茹,秦付绕.尤瑞克林联合依达拉奉对急性脑梗死患者血清同型半胱氨酸、血清超敏C-反应蛋白及D-二聚体水平的影响[J].药物评价研究,2019,42(1):117-120.[16]黄红娟,王增军,田作蓉,等.尤瑞克林联合静脉溶栓治疗急性脑梗塞的临床疗效及对血浆血小板、D-D、Fg水平的影响[J].现代生物医学进展,2019,19(6):1156-1159.[17]李海涛,张永强,孟令弟.尤瑞克林联合静脉溶栓剂对急性脑梗死患者治疗效果及血清学指标的影响[J].中华老年心脑血管病杂志,2020,22(2):169-172.[18]张昊,高立功,谭文刚,等.尤瑞克林在前循环急性大血管闭塞性卒中机械取栓术后的应用及对预后的影响[J].安徽医药,2023,27(2):409-413.[19]杨美丽,洪志林,蔡若蔚,等.尤瑞克林对局灶性脑缺血再灌注大鼠脑组织NF-κB、TNFa的影响及治疗效果探究[J].神经解剖学杂志,2018,34(5):585-590.[20]秦保健,李琳,唐荣盛,等.丁苯酞联合尤瑞克林对分水岭脑梗死急性期患者神经、血管内皮功能及血液流变学的影响[J].中国急救复苏与灾害医学杂志,2022,17(3):353-356.

相似文献/References:

[1]刘海威.延续性护理对脑梗死运动功能障碍患者生活质量及社会支持的影响[J].医学信息,2018,31(02):160.[doi:10.3969/j.issn.1006-1959.2018.02.062]
　LIU Hai-wei.Effect of Continuous Nursing on Quality of Life and Social Support in Patients with Motor Dysfunction of Cerebral Infarction[J].Journal of Medical Information,2018,31(09):160.[doi:10.3969/j.issn.1006-1959.2018.02.062]
[2]韩艳庆,董 成,徐 玲.脑梗死并发急腹症诊治分析[J].医学信息,2018,31(06):188.[doi:10.3969/j.issn.1006-1959.2018.06.068]
　HAN Yan-qing,DONG Cheng,XU Ling.Analysis of Diagnosis and Treatment of Acute Cerebral Infarction Complicating Acute Abdominal Disease[J].Journal of Medical Information,2018,31(09):188.[doi:10.3969/j.issn.1006-1959.2018.06.068]
[3]王明远,陈海燕,张延朋,等.颈动脉斑块、血同型半胱氨酸及血尿酸对短暂性脑缺血 发作进程的影响研究[J].医学信息,2018,31(08):65.[doi:10.3969/j.issn.1006-1959.2018.08.020]
　WANG Ming-yuan,CHEN Hai-yan,ZHANG Yan-peng,et al.Effects of Carotid Plaque,Homocysteine and Serum Uric Acid on Transient Ischemic Attack[J].Journal of Medical Information,2018,31(09):65.[doi:10.3969/j.issn.1006-1959.2018.08.020]
[4]甘雪梅.系统护理对脑梗死患者生活质量及满意度的影响[J].医学信息,2018,31(08):172.[doi:10.3969/j.issn.1006-1959.2018.08.062]
　GAN Xue-mei.Effect of Systematic Nursing on Quality of Life and Satisfaction of Patients with Cerebral Infarction[J].Journal of Medical Information,2018,31(09):172.[doi:10.3969/j.issn.1006-1959.2018.08.062]
[5]单 敏,常燕燕,赵大鹏,等.急性前循环脑梗死患者梗死体积与 血清NSE水平相关性研究[J].医学信息,2018,31(10):1.[doi:10.3969/j.issn.1006-1959.2018.10.001]
　SHAN Min,CHANG Yan-yan,ZHAO Da-peng,et al.Correlation between Infarct Volume and Serum NSE Level in Patients with Acute Anterior Circulation Cerebral Infarction[J].Journal of Medical Information,2018,31(09):1.[doi:10.3969/j.issn.1006-1959.2018.10.001]
[6]李福滔,张素平.单侧颈内动脉夹层致脑梗死1例报道[J].医学信息,2018,31(11):191.[doi:10.3969/j.issn.1006-1959.2018.11.065]
[7]张怀祥,段晓宇.脑梗死后认知障碍的病理学机制、相关危险因素及治疗[J].医学信息,2018,31(16):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
　ZHANG Huai-xiang,DUAN Xiao-yu.Pathological Mechanism,Related Risk Factors and Treatment of Cognitive Impairment after Cerebral Infarction[J].Journal of Medical Information,2018,31(09):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
[8]柳 星,卢会琴.脑梗死恢复期的临床路径实施效果分析[J].医学信息,2018,31(19):128.[doi:10.3969/j.issn.1006-1959.2018.19.038]
　LIU Xing,LU Hui-qin.Analysis of Clinical Path Implementation in the Recovery Period of Cerebral Infarction[J].Journal of Medical Information,2018,31(09):128.[doi:10.3969/j.issn.1006-1959.2018.19.038]
[9]杜 敏.血清小而密低密度脂蛋白胆固醇检测对预测脑梗死患者预后评估的价值[J].医学信息,2019,32(10):173.[doi:10.3969/j.issn.1006-1959.2019.10.058]
　DU Min.The Value of Serum Small,Dense Low-density Lipoprotein Cholesterol Test in Predicting the Prognosis of Patients with Cerebral Infarction[J].Journal of Medical Information,2019,32(09):173.[doi:10.3969/j.issn.1006-1959.2019.10.058]
[10]于红春,龙达志,曾良玉,等.普外科术后继发脑梗死的多因素Logistic回归分析[J].医学信息,2019,32(18):126.[doi:10.3969/j.issn.1006-1959.2019.18.042]
　YU Hong-chun,LONG Da-zhi,ZENG Liang-yu,et al.Multivariate Logistic Regression Analysis of Secondary Cerebral Infarction after General Surgery[J].Journal of Medical Information,2019,32(09):126.[doi:10.3969/j.issn.1006-1959.2019.18.042]

更新日期/Last Update: 1900-01-01